Details of Host Protein-DME Interaction (HOSPPI)
General Information of Drug-Metabolizing Enzyme (DME ID: DME0614) | |||||
---|---|---|---|---|---|
DME Name | Sulfotransferase 1C2 (SULT1C2), Homo sapiens | DME Info | |||
UniProt ID | |||||
EC Number | EC: 2.8.2.1 (Click to Show/Hide the Complete EC Tree) | ||||
Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
Interactome |
Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
---|---|---|---|---|---|
ICD Disease Classification 02 Neoplasms | |||||
ICD-11: 2A00 Brain cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Brain neuroblastoma | Significant hypomethylation | |||
Interaction Name | DNMT-SULT1C2 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 7.16E-22; delta-beta: -6.22E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the SULT1C2 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Sulfotransferase 1C2. As a result, the interaction between DNMT and SULT1C2 can significantly affect the drug-metabolizing process of Sulfotransferase 1C2. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD Disease Classification 05 Endocrine/nutritional/metabolic diseases | |||||
ICD-11: 5B81 Obesity | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Obesity | Significant hypermethylation | |||
Interaction Name | DNMT-SULT1C2 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypermethylation p-value: 9.17E-36; delta-beta: 3.20E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the SULT1C2 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme Sulfotransferase 1C2. As a result, the interaction between DNMT and SULT1C2 can significantly affect the drug-metabolizing process of Sulfotransferase 1C2. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.